Clinical Trials Directory

Trials / Completed

CompletedNCT00729911

Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD

Ablation vs. Amiodarone for Treatment of Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted ICD/CRTD

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
203 (actual)
Sponsor
Texas Cardiac Arrhythmia Research Foundation · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

1. To determine if catheter-based atrial fibrillation (AF) ablation is superior to Amiodarone treatment for symptomatic persistent/permanent AF in ICD/CRTD patients with an impaired left ventricular function. 2. Hypothesis: AF ablation is better than Amiodarone for subjects with symptomatic persistent or permanent AF and impaired LV function in terms of recurrence of AF, quality of life, 6-minute walk distance, EF and total number of hospitalizations.

Conditions

Interventions

TypeNameDescription
PROCEDUREAtrial Fibrillation ablationRadio-frequency catheter ablation of atrial fibrillation
DRUGAmiodaroneTaken orally on a daily basis.

Timeline

Start date
2008-10-01
Primary completion
2014-12-01
Completion
2015-12-01
First posted
2008-08-08
Last updated
2019-04-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00729911. Inclusion in this directory is not an endorsement.

Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD (NCT00729911) · Clinical Trials Directory